Skip to main content
Premium Trial:

Request an Annual Quote

Transgenomic Shares Slump Following Resignation of Board Chairman

NEW YORK (GenomeWeb News) – Transgenomic shares were down nearly 9 percent in mid-afternoon trading today following the company’s announcement this morning that the chairman of its board of directors, Collin D’Silva, had resigned.
Transgenomic shares reached a low of $.65 during the day, down 9.7 percent from their previous close of $.72.
D’Silva was a co-founder of Transgenomic and served as president and CEO from 1998 to 2006.
D’Silva has also resigned from his position as secretary of the company, though he will remain as director of mergers and acquisitions until at least March 31.
Transgenomic board member Gregory Sloma will serve as chairman on an interim basis until a new chairman is appointed. In addition, Craig Tuttle, the company’s current president and CEO, has been elected to the board to fill the vacancy created by D'Silva's resignation, and CFO Debra Schneider has been appointed secretary.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.